Calyxt, Inc. Stock Nasdaq
Equities
CBUS
US17166A1016
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.57 USD | 0.00% | 0.00% | 0.00% |
Mar. 21 | Cibus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 21 | Transcript : Cibus, Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
Financials (USD)
Sales 2024 * | 2.12M | Sales 2025 * | 8.34M | Capitalization | 343M |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | -87M | EV / Sales 2024 * | 162 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 41.1 x |
P/E ratio 2024 * |
-5.23
x | P/E ratio 2025 * |
-7.02
x | Employees | 183 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.27% |
Latest transcript on Calyxt, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Wade King
DFI | Director of Finance/CFO | 67 | - |
Peter Beetham
PSD | President | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Mark Finn
BRD | Director/Board Member | 81 | - |
Keith Walker
BRD | Director/Board Member | 76 | - |
1st Jan change | Capi. | |
---|---|---|
+8.94% | 219B | |
+7.48% | 183B | |
+11.34% | 133B | |
+25.35% | 108B | |
+0.61% | 63.06B | |
+12.49% | 52.02B | |
-0.62% | 48.2B | |
+0.08% | 40.37B | |
+13.24% | 39.35B |
- Stock Market
- Equities
- CLXT Stock
- CBUS Stock